Targeting tumor perfusion and oxygenation to improve the outcome of anticancer therapy

Frontiers in Pharmacology

Volumn 3 MAY, Issue , 2012, Pages

  Jordan, Bénédicte F ^a   Sonveaux, Pierre ^a  

^a UNIVERSITY OF LOUVAIN MEDICAL SCHOOL   (Belgium)

Author keywords

Chemotherapy; Hypoxia; Oxygen consumption; Provascu lar anticancer therapy; Radiotherapy; Tumor imaging.; Tumor vasculature; Vasodilation

Indexed keywords

ANGIOGENESIS INHIBITOR; CARBOGEN; CISPLATIN; CYCLO(DEXTRO TRYPTOPHYL DEXTRO ASPARTYLPROLYL DEXTRO VALYLLEUCYL); CYCLOPHOSPHAMIDE; ENDOTHELIN 1; FLUOROCARBON; GLUCOCORTICOID; METRONIDAZOLE; NICOTINAMIDE; NIMORAZOLE; NITRIC OXIDE; NITROIMIDAZOLE DERIVATIVE; SEMAXANIB; THALIDOMIDE; TIRAPAZAMINE; VANDETANIB;

ACIDIFICATION; ANTINEOPLASTIC ACTIVITY; ARTICLE; BOLD SIGNAL; CANCER CHEMOTHERAPY; CANCER CONTROL; CANCER RADIOTHERAPY; CATALYSIS; CLINICAL PROTOCOL; COLON TUMOR; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; DOPPLER FLOWMETRY; DRUG EFFICACY; DRUG SENSITIVITY; DRUG TARGETING; DRUG TOLERABILITY; ELECTRON SPIN RESONANCE; FLUORINE NUCLEAR MAGNETIC RESONANCE; GLIOMA; HEAD AND NECK CANCER; HUMAN; HYPERBARIC OXYGEN; HYPERTHERMIA; HYPOXIA; IONIZATION; NITROSYLATION; NON INVASIVE PROCEDURE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; OXIDATIVE PHOSPHORYLATION; OXIMETRY; OXYGEN CONSUMPTION; PERIPHERAL NEUROPATHY; POSITRON EMISSION TOMOGRAPHY; QUANTITATIVE ANALYSIS; RADIOSENSITIZATION; REOXYGENATION; SIGNAL TRANSDUCTION; TISSUE OXYGENATION; TISSUE PERFUSION; TREATMENT RESPONSE; TUMOR VASCULARIZATION; VASODILATATION;

EID: 84866034901     PISSN: None     EISSN: 16639812     Source Type: Journal    
DOI: 10.3389/fphar.2012.00094     Document Type: Article

References (121)

1. Ang, K. K. (2010). More lessons learned from the suffocation of hypoxia. J. Clin. Oncol. 28, 2941-2943.
2. Angelo, M., Singel, D. J., and Stam-ler, J. S. (2006). An S-nitrosothiol (SNO) synthase function of hemo-globin that utilizes nitrite as a sub-strate. Proc. Natl. Acad. Sci. U.S.A. 103, 8366-8371.
3. Ansiaux, R., Baudelet, C., Jordan, B. F., Beghein, N., Sonveaux, P., De Wever, J., Martinive, P., Gre-goire, V., Feron, O., and Gallez, B. (2005). Thalidomide radiosensitizes tumors through early changes in the tumor microenvironment. Clin. Cancer Res. 11, 743-750.
4. Ansiaux, R., Baudelet, C., Jordan, B. F., Crokart, N., Martinive, P., DeWever, J., Gregoire,V., Feron, O., and Gallez, B. (2006). Mechanism of reoxygena-tion after antiangiogenic therapy using SU5416 and its importance for guiding combined antitumor ther-apy. Cancer Res. 66, 9698-9704.
5. Ansiaux, R., DeWever, J., Gregoire, V., Feron, O., Jordan, B. F., and Gallez, B. (2009). Decrease in tumor cell oxygen consumption after treat-ment with vandetanib (ZACTIMA; ZD6474) and its effect on response to radiotherapy. Radiat. Res. 172, 584-591.
6. Arnold, W. P., Mittal, C. K., Katsuki, S., and Murad, F. (1977). Nitric oxide activates guanylate cyclase and increases guanosine 3':5'-cyclic monophosphate levels in various tis-sue preparations. Proc. Natl. Acad. Sci. U.S.A. 74, 3203-3207.
7. 2-weighted gradient-echo imaging: a marker of tumour acute hypoxia? Phys. Med. Biol. 49, 3389-3411.
8. 2-weighted GRE signal within tumors. NMR Biomed. 19, 69-76.
9. Baudelet, C., and Gallez, B. (2002). How does blood oxygen level-dependent (BOLD) contrast correlate with oxy-gen partial pressure (pO2) inside tumors? Magn. Reson. Med. 48, 980-986.
10. Biaglow, J. E., Manevich, Y., Leeper, D., Chance, B., Dewhirst, M. W., Jenkins, W. T., Tuttle, S. W., Wrob-lewski, K., Glickson, J. D., Stevens, C., and Evans, S. M. (1998). MIBG inhibits respiration: potential for radio-and hyperthermic sensitiza-tion. Int. J. Radiat. Oncol. Biol. Phys. 42, 871-876.
11. Boucher, Y., Leunig, M., and Jain, R. K. (1996). Tumor angiogenesis and interstitial hypertension. Cancer Res. 56, 4264-4266.
12. Bradley, D. P., Tessier, J. L., Checkley, D., Kuribayashi, H., Waterton, J. C., Kendrew, J., and Wedge, S. R. (2008). Effects of AZD2171 and vandetanib (ZD6474, Zactima) on haemody-namic variables in an SW620 human colon tumour model: an inves-tigation using dynamic contrast-enhanced MRI and the rapid clear-ance blood pool contrast agent,P792 (gadomelitol). NMR Biomed. 21, 42-52.
13. Brizel, D. M., Scully, S. P., Harrel-son, J. M., Layfield, L. J., Dodge, R. K., Charles, H. C., Samulski, T. V., Prosnitz, L. R., and Dewhirst, M. W. (1996). Radiation therapy and hyperthermia improve the oxygena-tion of human soft tissue sarcomas. Cancer Res. 56, 5347-5350.
14. Cardenas-Navia, L. I., Mace, D., Richardson, R. A., Wilson, D. F., Shan, S., and Dewhirst, M. W. (2008). The pervasive presence of fluctuating oxygenation in tumors. Cancer Res. 68, 5812-5819.
15. Choyke, P. L., Dwyer, A. J., and Knopp, M. V. (2003). Functional tumor imaging with dynamic contrast-enhanced magnetic resonance imag-ing. J. Magn. Reson. Imaging 17, 509-520.
16. Claes,A.,Wesseling, P., Jeuken, J., Maass, C., Heerschap, A., and Leenders, W. P. (2008). Antiangiogenic com-pounds interfere with chemother-apy of brain tumors due to vessel normalization. Mol. Cancer Ther. 7, 71-78.
17. Cristofanilli, M., Yamamura, Y., Kau, S. W., Bevers, T., Strom, S., Patan-gan, M., Hsu, L., Krishnamurthy, S., Theriault, R. L., and Hortobagyi, G. N. (2005). Thyroid hormone and breast carcinoma. Primary hypothy-roidism is associated with a reduced incidence of primary breast carci-noma. Cancer 103, 1122-1128.
18. Crokart, N., Jordan, B. F., Baudelet, C., Cron, G. O., Hotton, J., Rader-macher, K., Gregoire, V., Beghein, N., Martinive, P., Bouzin, C., Feron, O., and Gallez, B. (2007). Gluco-corticoids modulate tumor radia-tion response through a decrease in tumor oxygen consumption. Clin. Cancer Res. 13, 630-635.
19. Crokart, N., Radermacher, K., Jor-dan, B. F., Baudelet, C., Cron, G. O., Gregoire, V., Beghein, N., Bouzin, C., Feron, O., and Gallez, B. (2005a). Tumor radiosensitiza-tion by antiinflammatory drugs: evi-dence for a new mechanism involv-ing the oxygen effect. Cancer Res. 65, 7911-7916.
20. Crokart, N., Jordan, B. F., Baudelet, C., Ansiaux, R., Sonveaux, P., Grégoire, V., Beghein, N., DeWever, J., Bouzin, C., Feron, O., and Gallez, B. (2005b). Early reoxygenation in tumors after irradiation: determining factors and consequences for radiotherapy regi-mens using daily multiple fractions. Int. J. Radiat. Oncol. Biol. Phys. 63, 901-910.
21. Dewhirst, M. W., Kimura, H., Rehmus, S. W., Braun, R. D., Papahadjopou-los, D., Hong, K., and Secomb, T. W. (1996). Microvascular studies on the origins of perfusion-limited hypoxia. Br. J. Cancer Suppl. 27, S247-S251.
22. Dewhirst, M. W., Ong, E. T., Braun, R. D., Smith, B., Klitzman, B., Evans, S. M., and Wilson, D. (1999). Quantification of longitudinal tis-sue pO2 gradients in window cham-ber tumours: impact on tumour hypoxia. Br. J. Cancer 79,1717-1722.
23. Dewhirst, M. W., Thrall, D. E., Palmer, G., Schroeder, T., Vujaskovic, Z., Cecil, C. H., Macfall, J., and Wong, T. (2010). Utility of functional imaging in prediction or assessment of treat-ment response and prognosis fol-lowing thermotherapy. Int. J. Hyper-thermia 26, 283-293.
24. Feron, O. (2004). Targeting the tumor vascular compartment to improve conventional cancer therapy. Trends Pharmacol. Sci. 25, 536-542.
25. Folkman, J., Browder, T., and Palmblad, J. (2001). Angiogenesis research: guidelines for translation to clinical application. Thromb. Haemost. 86, 23-33.
26. Frerart, F., Sonveaux, P., Rath, G., Smoos, A., Meqor, A., Charlier, N., Jordan, B. F., Saliez, J., Noel, A., Dessy, C., Gallez, B., and Feron, O. (2008). The acidic tumor microenvi-ronment promotes the reconversion of nitrite into nitric oxide: towards a new and safe radiosensitizing strat-egy. Clin. Cancer Res. 14, 2768-2774.
27. Gallez, B., Baudelet, C., and Jordan, B. F. (2004). Assessment of tumor oxy-genation by electron paramagnetic resonance: principles and applica-tions. NMR Biomed. 17, 240-262.
28. Gallez, B., and Swartz, H. M. (2004). In vivo EPR: when, how and why? NMR Biomed. 17, 223-225.
29. Gatenby, R. A., Kessler, H. B., Rosen-blum, J. S., Coia, L. R., Moldofsky, P. J., Hartz, W. H., and Broder, G. J. (1988). Oxygen distribution in squa-mous cell carcinoma metastases and its relationship to outcome of radi-ation therapy. Int. J. Radiat. Oncol. Biol. Phys. 14, 831-838.
30. Gillies, R. J., Raghunand, N., Karcz-mar, G. S., and Bhujwalla, Z. M. (2002). MRI of the tumor microen-vironment. J. Magn. Reson. Imag. 16, 430-450.
31. Godber, B. L., Doel, J. J., Sapkota, G. P., Blake, D. R., Stevens, C. R., Eisenthal, R., and Harrison, R. (2000). Reduc-tion of nitrite to nitric oxide cat-alyzed by xanthine oxidoreductase. J. Biol. Chem. 275, 7757-7763.
32. Gray, L. H., Conger, A. D., Ebert, M., Hornsey, S., and Scott, O. C. (1953). The concentration of oxygen dis-solved in tissues at the time of irradi-ation as a factor in radiotherapy. Br. J. Radiol. 26, 638-648.
33. Gredilla, R., Lopez, T. M., Portero-Otin, M., Pamplona, R., and Barja, G. (2001). Influence of hyper-and hypothyroidism on lipid peroxida-tion, unsaturation of phospholipids, glutathione system and oxidative damage to nuclear and mitochondr-ial DNA in mice skeletal muscle. Mol. Cell. Biochem. 221, 41-48.
34. Haynes, W. G., and Webb, D. J. (1994). Contribution of endogenous gener-ation of endothelin-1 to basal vascu-lar tone. Lancet. 344, 852-854.
35. Hercbergs, A., and Leith, J. T. (1993). Spontaneous remission of metasta-tic lung cancer following myxedema coma - an apoptosis-related phe-nomenon? J. Natl. Cancer Inst. 85, 1342-1343.
36. Hercbergs, A. A., Goyal, L. K., Suh, J. H., Lee, S., Reddy, C. A., Cohen, B. H., Stevens, G. H., Reddy, S. K., Peereboom, D. M., Elson, P. J., Gupta, M. K., and Barnett, G. H. (2003). Propylthiouracil-induced chemical hypothyroidism with high-dose tamoxifen prolongs survival in recurrent high grade glioma: a phase I/II study. Anticancer Res. 23, 617-626.
37. Hockel, M., Vorndran, B., Schlenger, K., Baussmann, E., and Knapstein, P. G. (1993). Tumor oxygenation: a new predictive parameter in locally advanced cancer of the uterine cervix. Gynecol. Oncol. 51, 141-149.
38. Holland, M. A., and Kozlowski, L. M. (1986). Clinical features and man-agement of cyanide poisoning. Clin. Pharm. 5, 737-741.
39. Horsman, M. R., and van der Kogel, A. J. (2009). "Therapeutic approaches to tumor hypoxia," in Basic Clinical Radiobiology, 4th Edn, eds M. Joiner and A. J. van der Kogel (London: H. Arnold), 233-245.
40. Hoskin, P., Rojas, A., Bentzen, S., and Saunders, M. (2009). "Randomised III trial of radiotherapy with concurrent carbogen and nicoti-namide in locally advanced bladder cancer," in Conference Proceedings ASTRO, Chicago.
41. Huang, A., and Koller, A. (1997). Endothelin and prostaglandin h2 enhance arteriolar myogenic tone in hypertension. Hypertension 30, 1210-1215.
42. Jain, R. K. (2001). Normalizing tumor vasculature with anti-angiogenic therapy: a new paradigm for com-bination therapy. Nat. Med.7, 987-989.
43. Jennings, D., Raghunand, N., and Gillies, R. J. (2008). Imaging hemo-dynamics. Cancer Metastasis Rev. 27, 589-613.
44. Jia, L., Bonaventura, C., Bonaven-tura, J., and Stamler, J. S. (1996). S-nitrosohaemoglobin: a dynamic activity of blood involved in vascular control. Nature 380, 221-226.
45. Jones, E. L., Oleson, J. R., Prosnitz, L. R., Samulski, T. V., Vujaskovic, Z., Yu, D., Sanders, L. L., and Dewhirst, M. W. (2005). Randomized trial of hyperthermia and radiation for superficial tumors. J. Clin. Oncol. 23, 3079-3085.
46. Jones, E. L., Samulski, T. V., Dewhirst, M. W., Alvarez-Secord, A., Berchuck, A., Clarke-Pearson, D., Havrilesky, L. J., Soper, J., and Prosnitz, L. R. (2003). A pilot phase II trial of con-current radiotherapy, chemother-apy, and hyperthermia for locally advanced cervical carcinoma. Can-cer 98, 277-282.
47. Jordan, B. F., Beghein, N., Crokart, N., Baudelet,C.,Gregoire,V.,and Gallez, B. (2006a). Preclinical safety and antitumor efficacy of insulin com-bined with irradiation. Radiother. Oncol. 81, 112-117.
48. Jordan, B. F., Crokart, N., Baudelet, C., Cron, G. O., Ansiaux, R., and Gallez, B. (2006b). Complex rela-tionship between changes in oxy-genation status and changes in R*2: the case of insulin and NS-398, two inhibitors of oxygen consumption. Magn. Reson. Med. 56, 637-643.
49. Jordan, B. F., Christian, N., Crokart, N., Gregoire,V., Feron, O., and Gallez, B. (2007). Thyroid status is a key mod-ulator of tumor oxygenation: impli-cation for radiation therapy. Radiat. Res. 168, 428-432.
50. Jordan, B. F., Cron, G. O., and Gallez, B. (2009). Rapid monitoring of oxy-genation by 19F magnetic resonance imaging: simultaneous comparison with fluorescence quenching. Magn. Reson. Med. 61, 634-638.
51. Jordan, B. F., and Gallez, B. (2010). Sur-rogate MR markers of response to chemo-or radiotherapy in associa-tion with co-treatments: a retrospec-tive analysis of multi-modal stud-ies. Contrast Media Mol. Imaging 5, 323-332.
52. Jordan, B. F., and Gallez, B. (2011). "Non-invasive imaging of the tumor microenvironment," in Tumor Microenvirnment, ed. D. W. Sie-mann (Oxford: John Wiley & Sons Inc.), 229-270.
53. Jordan, B. F., Gregoire, V., Demeure, R. J., Sonveaux, P., Feron, O., O'Hara, J., Vanhulle, V. P., Delzenne, N., and Gallez, B. (2002). Insulin increases the sensitivity of tumors to irradia-tion: involvement of an increase in tumor oxygenation mediated by a nitric oxide-dependent decrease of the tumor cells oxygen consump-tion. Cancer Res. 62, 3555-3561.
54. Jordan, B. F., Misson, P., Demeure, R., Baudelet,C.,Beghein,N.,and Gallez, B. (2000). Changes in tumor oxy-genation/perfusion induced by the no donor, isosorbide dinitrate, in comparison with carbogen: mon-itoring by EPR and MRI. Int. J. Radiat. Oncol. Biol. Phys. 48, 565-570.
55. Jordan, B. F., Peeterbroeck, J., Karroum, O., Diepart, C., Magat, J., Gregoire, V., and Gallez, B. (2010). Capto-pril and S-nitrosocaptopril as potent radiosensitizers: comparative study and underlying mechanisms. Cancer Lett. 293, 213-219.
56. Jordan, B. F., Sonveaux, P., Feron, O., Gregoire, V., Beghein, N., Dessy, C., and Gallez, B. (2004). Nitric oxide as a radiosensitizer: evidence for an intrinsic role in addition to its effect on oxygen delivery and consump-tion. Int. J. Cancer 109, 768-773.
57. Kaanders, J. H., Bussink, J., and van der Kogel, A. J. (2002). ARCON: a novel biology-based approach in radio-therapy. Lancet Oncol. 3, 728-737.
58. Kelleher, D. K., Engel, T., and Vaupel, P. W. (1995). Changes in microregional perfusion,oxygenation,ATP and lac-tate distribution in subcutaneous rat tumours upon water-filtered IR-A hyperthermia. Int. J. Hyperthermia 11, 241-255.
59. Kimberg, D. V., Loud, A. V., and Wiener, J. (1968). Cortisone-induced alter-ations in mitochondrial function and structure. J. Cell Biol. 37, 63-79.
60. Kimura, H., Braun, R. D., Ong, E. T., Hsu, R., Secomb, T. W., Papa-hadjopoulos, D., Hong, K., and Dewhirst, M. W. (1996). Fluctu-ations in red cell flux in tumor microvessels can lead to tran-sient hypoxia and reoxygenation in tumor parenchyma. Cancer Res. 56, 5522-5528.
61. Koh, W. J., Bergman, K. S., Rasey, J. S., Peterson, L. M., Evans, M. L., Graham, M. M., Grierson, J. R., Lindsley, K. L., Lewellen, T. K., and Krohn, K. A. (1995). Evalua-tion of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography. Int. J. Radiat. Oncol. Biol. Phys. 33, 391-398.
62. Kuppusamy, P., Chzhan, M., and Zweier, J. L. (2003). "Principles of imag-ing in vivo EPR (ESR)," in The-ory and Applications: Biological Mag-netic Resonance, Vol. 18, ed. L. J. Berliner (New York: Kluwer Acade-mic/Plenum), 99-152.
63. Maguire, J. J., and Davenport, A. P. (1995). ETA receptor-mediated con-strictor responses to endothelin pep-tides in human blood vessels in vitro. Br. J. Pharm. 115, 191-197.
64. Magat, J., Jordan, B. F., Cron, G. O., and Gallez, B. (2010). Noninvasive map-ping of spontaneous fluctuations in tumor oxygenation using 19F MRI. Med. Phys. 37, 5434-5441.
65. Maguire, J. J., and Davenport, A. P. (1995). ETA receptor-mediated con-strictor responses to endothelin pep-tides in human blood vessels in vitro. Br. J. Pharm. 115, 191-197.
66. Martinive, P., De Wever, J., Bouzin, C., Baudelet, C., Sonveaux, P., Gre-goire, V., Gallez, B., and Feron, O. (2006). Reversal of temporal and spatial heterogeneities in tumor per-fusion identifies the tumor vascular tone as a tunable variable to improve drug delivery. Mol. Cancer Ther. 5, 1620-1627.
67. Mason, R. P., Rodbumrung, W., and Antich, P. P. (1996). Hexafluoroben-zene: a sensitive 19F NMR indi-cator of tumor oxygenation. NMR Biomed. 9, 125-134.
68. Mattson, J., Appelgren, L., Karlsson, L., and Peterson, H. I. (1978). Influence of vasoactive drugs and ischaemia on intra-tumour blood flow distribution. Eur. J. Cancer 14, 761-764.
69. McDonald, D. M., and Baluk, P. (2002). Significance of blood vessel leakiness in cancer. Cancer Res. 62,5381-5385.
70. McMahon, T. J., Moon, R. E., Luschinger, B. P., Carraway, M. S., Stone, A. E., Stolp, B. W., Gow, A. J., Pawloski, J. R., Watke, P., Singel, D. J., Piantadosi, C. A., and Stamler, J. S. (2002). Nitric oxide in the human respiratory cycle. Nat. Med. 8, 711-717.
71. Michel, J. B., Feron, O., Sase, K., Prab-hakar, P., and Michel, T. (1997). Caveolin versus calmodulin. Coun-terbalancing allosteric modulators of endothelial nitric oxide synthase. J. Biol. Chem. 272, 25907-25912.
72. Mishkin, S. Y., Pollack, R., Yalovsky, M. A., Morris, H. P., and Mishkin, S. (1981). Inhibition of local and metastatic hepatoma growth and prolongation of survival after induc-tion of hypothyroidism. Cancer Res. 41, 3040-3045.
73. Modin, A., Bjorne, H., Herulf, M., Alv-ing, K., Weitzberg, E., and Lundberg, J. O. (2001). Nitrite-derived nitric oxide: a possible mediator of "acidic-metabolic" vasodilation. Acta Phys-iol. Scand. 171, 9-16.
74. Moon, E. J., Sonveaux, P., Porporato, P. E., Danhier, P., Gallez, B., Batinic-Haberle, I., Nien, Y. C., Schroeder, T., and Dewhirst, M. W. (2010). NADPH oxidase-mediated reactive oxygen species production activates hypoxia-inducible factor-1 (HIF-1) via the ERK pathway after hyperther-mia treatment. Proc. Natl. Acad. Sci. U.S.A. 107, 20477-20482.
75. Moya, M. P., Gow, A. J., Califf, R. M., Goldberg, R. N., and Stamler, J. S. (2002). Inhaled ethyl nitrite gas for persistent pulmonary hyperten-sion of the newborn. Lancet 360, 141-143.
76. Munn, L. L. (2003). Aberrant vascu-lar architecture in tumors and its importance in drug-based therapies. Drug Discov. Today 8, 396-403.
77. O'Connor, J. P., Jackson, A., Buonac-corsi, G. A., Buckley, D. L., Roberts, C., Watson, Y., Cheung, S., McGrath, D. M., Naish, J. H., Rose, C. J., Dark, P. M., Jayson, G. C., and Parker, G. J. (2007). Organ-specific effects of oxygen and carbogen gas inhala-tion on tissue longitudinal relax-ation times. Magn. Reson. Med. 58, 490-496.
78. 2 modulation by oxygen and carbogen. Magn. Reson. Med. 61, 75-83.
79. Ogawa, S., Lee, T. M., Kay, A. R., and Tank, D. W. (1990). Brain mag-netic resonance imaging with con-trast dependent on blood oxygena-tion. Proc. Natl. Acad. Sci. U.S.A. 87, 9868-9872.
80. Okunieff, P., Hoeckel, M., Dunphy, E. P., Schlenger, K., Knoop, C., and Vau-pel, P. (1993). Oxygen tension dis-tributions are sufficient to explain the local response of human breast tumors treated with radiation alone Int. J. Radiat. Oncol. Biol. Phys. 26, 631-636.
81. Overgaard, J. (2007). Hypoxic radiosen-sitization: adored and ignored. J. Clin. Oncol. 25, 4066-4074.
82. Overgaard, J., Hansen, H. S., Over-gaard, M., Bastholt, L., Berthelsen, A., Specht, L., Lindelov, B., and Jorgensen, K. (1998). A random-ized double-blind phase III study of nimorazole as a hypoxic radiosen-sitizer of primary radiotherapy in supraglottic larynx and pharynx carcinoma. Results of the Dan-ish Head and Neck Cancer Study (DAHANCA) Protocol 5-85. Radio-ther. Oncol. 46, 135-146.
83. Padhani, A. R., Krohn, K. A., Lewis, J. S., and Alber, M. (2007). Imaging oxy-genation of human tumours. Eur. Radiol. 17, 861-872.
84. Patan, S., Munn, L. L., and Jain, R. K. (1996). Intussusceptive microvas-cular growth in a human colon adenocarcinoma xenograft: a novel mechanism of tumor angiogenesis. Microvasc. Res. 51, 260-272.
85. Peters, L. J., O'Sullivan, B., Giralt, J., Fitzgerald, T. J., Trotti, A., Bernier, J., Bourhis, J., Yuen, K., Fisher, R., and Rischin, D. (2010). Critical impact of radiotherapy protocol compli-ance and quality in the treatment of advanced head and neck cancer: results from TROG 02.02. J. Clin. Oncol. 28, 2996-3001.
86. Peterson, H. I., and Mattson, J. (1984). Vasoactive drugs and tumor blood flow. Biorheology 21, 503-508.
87. Pilkington, G. J., Parker, K., and Murray, S. A. (2008). Approaches to mito-chondrially mediated cancer ther-apy. Semin. Cancer Biol. 18, 226-235.
88. Rajendran, J. G., Schwartz, D. L., O'Sullivan, J., Peterson, L. M., Ng, P., Scharnhorst, J., Grierson, J. R., and Krohn, K. A. (2006). Tumor hypoxia imaging with [F-18] flu-oromisonidazole positron emission tomography in head and neck can-cer. Clin. Cancer Res. 12, 5435-5441.
89. Rajendran, J. G., Wilson, D. C., Conrad, E. U., Peterson, L. M., Bruckner, J. D., Rasey, J. S., Chin, L. K., Hofstrand, P. D., Grierson, J. R., Eary, J. F., and Krohn, K. A. (2003). [(18)F]FMISO and [(18)F]FDG PET imaging in soft tissue sarcomas: correlation of hypoxia, metabolism and VEGF expression. Eur.J.Nucl.Med.Mol. Imaging 30, 695-704.
90. Rischin, D., Peters, L., Fisher, R., Macann, A., Denham, J., Poulsen, M., Jackson, M., Kenny, L., Penni-ment, M., Corry, J., Lamb, D., and McClure, B. (2005). Tirapazamine, cisplatin, and radiation versus flu-orouracil, cisplatin, and radiation in patients with locally advanced head and neck cancer: a random-ized phase II trial of the Trans-Tasman Radiation Oncology Group (TROG 98.02). J. Clin. Oncol. 23, 79-87.
91. Rischin, D., Peters, L., Hicks, R., Hughes, P., Fisher, R., Hart, R., Sexton, M., D'Costa, I., and von Roemeling, R. (2001). Phase I trial of concurrent tirapazamine, cisplatin, and radiotherapy in patients with advanced head and neck cancer. J. Clin. Oncol. 19, 535-542.
92. Rojas, A., Joiner, M. C., Hodgkiss, R. J., Carl, U., Kjellen, E., and Wil-son, G. D. (1992). Enhancement of tumor radiosensitivity and reduced hypoxia-dependent binding of a 2-nitroimidazole with normobaric oxygen and carbogen: a therapeutic comparison with skin and kidneys. Int. J. Radiat. Oncol. Biol. Phys. 23, 361-366.
93. Secomb, T. W., Hsu, R., Ong, E. T., Gross, J. F., and Dewhirst, M. W. (1995). Analysis of the effects of oxy-gen supply and demand on hypoxic fraction in tumors. Acta Oncol 34, 313-316.
94. Segers, J., Crokart, N., Danhier, P., Gregoire, V., Jordan, B. F., and Gallez, B. (2010). Use of xanthinol nicotinate as a co-treatment for radio- and chemotherapy in experimental tumors. Int. J. Cancer 126, 583-588.
95. Shichiri, M., Hirata, Y., Nakajima, T., Ando, K., Imai, T., Yanagisawa, M., Masaki, T., and Marumo, F. (1991). Endothelin-1 is an autocrine/paracrine growth factor for human cancer cell lines. J. Clin. Invest. 87, 1867-1871.
96. Shoemaker, J. P., and Dagher, R. K. (1979). Remissions of mammary adenocarcinoma in hypothyroid mice given 5-fluorouracil and chloroquine phosphate. J. Natl. Cancer Inst. 62, 1575-1578.
97. Simon, N., Jolliet, P., Morin, C., Zini, R., Urien, S., and Tillement, J. P. (1998). Glucocorticoids decrease cytochrome c oxidase activity of isolated rat kid-ney mitochondria. FEBS Lett. 435, 25-28.
98. Sonveaux, P. (2008). Provascular strategy:targeting functional adaptations of mature blood vessels in tumors to selectively influence the tumor vascular reactivity and improve cancer treatment. Radiother. Oncol. 86, 300-313.
99. Sonveaux, P., Brouet, A., Havaux, X., Gregoire, V., Dessy, C., Balligand, J. L., and Feron, O. (2003). Irradiation-induced angiogenesis through the up-regulation of the nitric oxide pathway: implications for tumor radiotherapy. Cancer Res. 63, 1012-1019.
100. Sonveaux, P., Dessy, C., Brouet, A., Jordan, B. F., Gregoire, V., Gallez, B., Balligand, J. L., and Feron, O. (2002). Modulation of the tumor vasculature functionality by ionizing radiation accounts for tumor radiosensitization and pro-motes gene delivery. FASEB J. 16, 1979-1981.
101. Sonveaux, P., Dessy, C., Martinive, P., Havaux, X., Jordan, B. F., Gallez, B., Gregoire, V., Balligand, J. L., and Feron, O. (2004). Endothelin-1 is a critical mediator of myogenic tone in tumor arterioles: implications for cancer treatment. Cancer Res. 64, 3209-3214.
102. Sonveaux, P., and Feron, O. (2005). "Nitric oxide and tumor biology," in Nitric Oxide, Cell Signaling, and Gene Expression, eds S. Lamas and E. Cadenas (Boca Raton: CRC Press), 393-418.
103. Sonveaux, P., Frerart, F., Bouzin, C., Brouet, A., DeWever, J., Jordan, B. F., Gallez, B., and Feron, O. (2007a). Irradiation promotes Akt-targeting therapeutic gene deliv-ery to the tumor vasculature. Int. J. Radiat. Oncol. Biol. Phys. 67, 1155-1162.
104. Sonveaux, P., Lobysheva, I. I., Feron, O., and McMahon, T. J. (2007b). Transport and peripheral bioactivi-ties of nitrogen oxides carried by red blood cell hemoglobin: role in oxy-gen delivery. Physiology (Bethesda) 22, 97-112.
105. Sonveaux,P.,Jordan,B. F.,Gallez,B.,and Feron, O. (2009). Nitric oxide deliv-ery to cancer: why and how? Eur. J. Cancer 45, 1352-1369.
106. Sonveaux, P., Kaz, A. M., Snyder, S. A., Richardson, R. A., Cardenas-Navia, L. I., Braun, R. D., Pawloski, J. R., Tozer, G. M., Bonaventura, J., McMahon, T. J., Stamler, J. S., and Dewhirst,M.W. (2005). Oxygen reg-ulation of tumor perfusion by S-nitrosohemoglobin reveals a pressor activity of nitric oxide. Circ. Res. 96, 1119-1126.
107. Stamler, J. S., Jia, L., Eu, J. P., McMahon, T. J., Demchenko, I. T., Bonaventura, J., Gernert, K., and Piantadosi, C. A. (1997). Blood flow regulation by S-nitrosohemoglobin in the physio-logical oxygen gradient. Science 276, 2034-2037.
108. Stone, H. B., Brown, J. M., Phillips, T. L., and Sutherland, R. M. (1993). Oxygen in human tumors: correlations between methods of measurement and response to therapy. Summary of a workshop held November 19-20, 1992, at the National Cancer Institute, Bethesda, Maryland. Radiat. Res. 136, 422-434.
109. Stratmann, A., Risau, W., and Plate, K. H. (1998). Cell type-specific expression of angiopoietin-1 and angiopoietin-2 suggests a role in glioblastoma angiogenesis. Am. J. Pathol. 153, 1459-1466.
110. Swartz, H. M., Khan, N., Buckey, J., Comi, R., Gould, L., Grinberg, O., Hartford, A., Hopf, H., Hou, H., Hug, E., Iwasaki, A., Lesniewski, P., Salikhov, I., and Walczak, T. (2004). Clinical applications of EPR: overview and perspectives. NMR Biomed. 17, 335-351.
111. Tatum, J. L., Kelloff, G. J., Gillies, R. J., Arbeit, J. M., Brown, J. M., Chao, K. S., Chapman, J. D., Eckelman, W. C., Fyles, A. W., Giaccia, A. J., Hill, R. P., Koch, C. J., Krishna, M. C., Krohn, K. A., Lewis, J. S., Mason, R. P., Melillo, G., Padhani, A. R., Powis, G., Rajendran, J. G., Reba, R., Robinson, S. P., Semenza, G. L., Swartz, H. M., Vaupel, P., Yang, D., Croft, B., Hoffman, J., Liu, G., Stone, H., and Sullivan, D. (2006). Hypoxia: importance in tumor biol-ogy, noninvasive measurement by imaging, and value of its measure-ment in the management of can-cer therapy. Int. J. Radiat. Biol. 82, 699-757.
112. Theodossiou, C., Skrepnik, N., Robert, E. G., Prasad, C., Axelrad, T. W., Schapira, D. V., and Hunt, J. D. (1999). Propylthiouracil-induced hypothyroidism reduces xenograft tumor growth in athymic nude mice. Cancer 86, 1596-1601.
113. Thomas, C. D., Chavaudra, N., Martin, L., and Guichard, M. (1994). Corre-lation between radiosensitivity, per-centage hypoxic cells and pO2 mea-surements in one rodent and two human tumor xenografts. Radiat. Res. 139, 1-8.
114. Tofts, P. S., Brix, G., Buckley, D. L., Evel-hoch,J. L.,Henderson,E.,Knopp,M. V., Larsson, H. B., Lee, T. Y., Mayr, N. A., Parker, G. J., Port, R. E., Tay-lor, J., and Weisskoff, R. M. (1999). Estimating kinetic parameters from dynamic contrast-enhanced T(1)-weighted MRI of a diffusable tracer: standardized quantities and sym-bols. J. Magn. Reson. Imaging 10, 223-232.
115. Tong, R. T., Boucher, Y., Kozin, S. V., Winkler, F., Hicklin, D. J., and Jain, R. K. (2004). Vascular normalization by vascular endothelial growth fac-tor receptor 2 blockade induces a pressure gradient across the vas-culature and improves drug pene-tration in tumors. Cancer Res. 64, 3731-3736.
116. Vanin, A. F., Bevers, L. M., Slama-Schwok, A., and van Faassen, E. E. (2007). Nitric oxide synthase reduces nitrite to NO under anoxia. Cell.Mol.LifeSci.64, 96-103.
117. Vaupel, P., Okunieff, P., and Neuringer, L. J. (1989). Blood flow, tis-sue oxygenation, pH distribution, and energy metabolism of murine mammary adenocarcinomas during growth. Adv. Exp. Med. Biol. 248, 835-845.
118. Vujaskovic,Z.,Rosen,E. L.,Blackwell,K. L.,Jones,E. L.,Brizel,D. M.,Prosnitz, L. R., Samulski, T. V., and Dewhirst, M. W. (2003). Ultrasound guided pO2 measurement of breast cancer reoxygenation after neoadjuvant chemotherapy and hyperthermia treatment. Int. J. Hyperthermia 19, 498-506.
119. Zhao, D., Jiang, L., and Mason, R. P. (2004). Measuring changes in tumor oxygenation. Meth. Enzymol. 386, 378-418.
120. Zlotecki, R. A., Baxter, L. T., Boucher, Y., and Jain, R. K. (1995). Pharmacologic modification of tumor blood flow and intersti-tial fluid pressure in a human tumor xenograft: network analysis and mechanistic interpretation. Microvasc. Res. 50, 429-443.
121. Zweier, J. L., Samouilov, A., and Kuppusamy, P. (1999). Non-enzymatic nitric oxide synthesis in biological systems. Biochim. Biophys. Acta 1411, 250-262.